Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

McGill University

$210,000.00

Maternal Psychotropic Medication Use in Pregnancy And Child Suicidal Behavior: A Register-Based Target Trial Emulation

FY 2024-25

Summary
Albeit preventable, suicide is a leading cause of death worldwide, affecting thousands of people. For the development of prevention strategies, it is crucial to identify modifiable factors of suicide risk. Children of mothers with mental disorders experience excess risks of suicidal behavior during their life, thus, it is critical to treat maternal mental health. Although psychotropic mediations (antidepressants, anxiolytics, antipsychotics) are effective treatments, they may adversely affect children's development and increase risks of suicidal behavior when used during pregnancy. In this context, clinical decision making is complex and need to balance different risks. First, the risk for mothers (including of suicide) when stopping psychotropic medication during pregnancy. Second, the risk for the children exposed to untreated maternal mental disorders. Third, the risk for the child to suffer long-term consequences due to the exposure to psychotropic mediations in utero. The current project focuses on this important yet understudied topic. Using data from 1.7 million individuals representative of the entire Danish population, we aim to understand whether mother's use of medication for mental disorders during pregnancy affects her child's risk of suicidal behavior later in time. Further, we aim to understand whether stopping these medications during pregnancy affects the mother's risk of suicide (both during and after pregnancy) and her child's risk of suicide. By using advanced statistical methods that mimic the conditions of a clinical trial, this study will provide the most reliable evidence to date on this topic. This research has important implications for clinical guidelines, helping doctors and patients to make informed decisions about using psychotropic medications in pregnancy. Ultimately, this research aims to reduce the risk of suicide by improving mental health care for both mothers and their children, benefiting individuals, families, and society.
Program
CIHR Fellowship
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
513845
Name
Collet Ophélie A
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Health Research Training A - Post-PhD (HTA)
Projecttitle
Maternal Psychotropic Medication Use in Pregnancy And Child Suicidal Behavior: A Register-Based Target Trial Emulation
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$210,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Causal Inference; Mental Health; Perinatalogy; Pregnancy; Psychotropic Medication; Register-Based Data; Suicidology; Target Trial Emulation
Abstract
Albeit preventable, suicide is a leading cause of death worldwide, affecting thousands of people. For the development of prevention strategies, it is crucial to identify modifiable factors of suicide risk. Children of mothers with mental disorders experience excess risks of suicidal behavior during their life, thus, it is critical to treat maternal mental health. Although psychotropic mediations (antidepressants, anxiolytics, antipsychotics) are effective treatments, they may adversely affect children's development and increase risks of suicidal behavior when used during pregnancy. In this context, clinical decision making is complex and need to balance different risks. First, the risk for mothers (including of suicide) when stopping psychotropic medication during pregnancy. Second, the risk for the children exposed to untreated maternal mental disorders. Third, the risk for the child to suffer long-term consequences due to the exposure to psychotropic mediations in utero. The current project focuses on this important yet understudied topic. Using data from 1.7 million individuals representative of the entire Danish population, we aim to understand whether mother's use of medication for mental disorders during pregnancy affects her child's risk of suicidal behavior later in time. Further, we aim to understand whether stopping these medications during pregnancy affects the mother's risk of suicide (both during and after pregnancy) and her child's risk of suicide. By using advanced statistical methods that mimic the conditions of a clinical trial, this study will provide the most reliable evidence to date on this topic. This research has important implications for clinical guidelines, helping doctors and patients to make informed decisions about using psychotropic medications in pregnancy. Ultimately, this research aims to reduce the risk of suicide by improving mental health care for both mothers and their children, benefiting individuals, families, and society.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Collet, Ophélie A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $210,000~ $0~
McGill University - $210,000 Grant (2024-25) | Canada Spends